SUZUKEN : Notice Regarding Resolution to Acquire Treasury Shares (Acquisition of treasury shares in accordance with the Articles of Incorporation pursuant to the provision of Article 459, Paragraph 1 of the Companies Act)
June 01, 2017 at 08:06 pm EDT
Share
Press Release Suzuken Co., Ltd.
Hiromi Miyata, President and CEO (Stock Code: 9987)
May 11, 2017
Securities Traded: First Sections of the Tokyo and Nagoya Stock Exchanges and the Sapporo Securities Exchange
Contact: Shigeru Asano, Director and Senior Executive Officer; Senior General Manager, Corporate Management Headquarters
Tel.: +81-52-961-2331
Notice Regarding Resolution to Acquire Treasury Shares
(Acquisition of treasury shares in accordance with the Articles of Incorporation pursuant to the provision of Article 459, Paragraph 1 of the Companies Act)
Suzuken Co., Ltd. (hereinafter the "Company") announced today that the Board of Directors resolved at a meeting held on May 11, 2017 the following items pertaining to the acquisition of treasury shares in accordance with the Articles of Incorporation pursuant to the provision of Article 459 Paragraph 1 of the Companies Act.
Reason for Acquisition of Treasury Shares
To execute agile capital policies in response to changes in the economic environment.
Details of Items Pertaining to the Acquisition
Type of Shares to Be Acquired Shares of common stock
Number of Shares to Be Acquired 2,200,000 shares (upper limit)
(Ratio of total number of issued shares (excluding treasury shares) 2.28%)
Total Amount of the Acquisition Price of the Shares ¥8.5 billion (upper limit)
Acquisition Period May 15, 2017 to June 30, 2017
(Reference) Status of treasury shares holdings as of March 31, 2017
Total number of shares issued (excluding treasury shares) 96,622,400 shares Number of treasury shares 6,721,683 shares
Suzuken Co. Ltd. published this content on 11 May 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 02 June 2017 00:06:18 UTC.
Original documenthttp://v4.eir-parts.net/v4Contents/View.aspx?template=announcement&sid=36333&code=9987
Public permalinkhttp://www.publicnow.com/view/87AEF060BD159A75865A857781FADA7612C923EA
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
SUZUKEN : Notice Regarding Resolution to Acquire Treasury Shares (Acquisition of treasury shares in accordance with the Articles of Incorporation pursuant to the provision of Article 459, Paragraph 1 of the Companies Act)